"The Cost of Evidence: Examining the FDA's Treatment of Critically-Need" by Julie Dorais J.D., M.P.H.

Article Title

The Cost of Evidence: Examining the FDA's Treatment of Critically-Needed Drugs from an Ex Ante Perspective

Authors

Document Type

Articles

Recommended Citation

Dorais, Julie J.D., M.P.H. (2015) "The Cost of Evidence: Examining the FDA's Treatment of Critically-Needed Drugs from an Ex Ante Perspective," North Carolina Central University Science & Intellectual Property Law Review: Vol. 8: Iss. 1, Article 2.
Available at: https://archives.law.nccu.edu/siplr/vol8/iss1/2

Download

Included in

Evidence Commons, Food and Drug Law Commons, Health Law and Policy Commons

COinS

Article Title

Authors

Document Type

Recommended Citation

Included in

Search